BFC Planning’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$23 – 3539
2026
Q2
$23 Buy
+2
New +$23 ﹤0.01% 3392

Other funds holding INKT

BFC Planning's INKT Position: Q3 2026 in Review

BFC Planning sold out of MiNK Therapeutics (INKT) in Q3 2026, closing a stake of 2 shares — an estimated $23 sold.

BFC Planning first reported a position in INKT in Q2 2026 and held it in 1 quarter. The position peaked at $23 in Q2 2026. 22 funds tracked by Wall St. Rank hold INKT as of Q3 2026.

  • BFC Planning reported no remaining MiNK Therapeutics position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 2 MiNK Therapeutics shares in Q3 2026, an estimated $23.
  • BFC Planning first reported a position in MiNK Therapeutics in Q2 2026 and held it in 1 quarter.
  • BFC Planning's MiNK Therapeutics position peaked at $23 in Q2 2026.
  • 22 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.